InvestorsHub Logo
Followers 26
Posts 3558
Boards Moderated 0
Alias Born 11/12/2018

Re: Bolio98 post# 405343

Thursday, 03/09/2023 8:53:37 AM

Thursday, March 09, 2023 8:53:37 AM

Post# of 426450
Bolio, IMO it’s not likely. Especially based on the following VERY informative article on infringement suits and patent challenges using AMRN as a case study and the history of AMRN vs Hikma infringement suits. For those interested in the legal side of things. Long but worth the read.

https://jipel.law.nyu.edu/pharmaceutical-patent-two-step-the-adverse-advent-of-amarin-v-hikma-type-litigation/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News